A detailed history of Xponance, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Xponance, Inc. holds 33,294 shares of RPRX stock, worth $836,345. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,294
Previous 31,704 5.02%
Holding current value
$836,345
Previous $836,000 12.56%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$25.63 - $29.27 $40,751 - $46,539
1,590 Added 5.02%
33,294 $941,000
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $15,913 - $18,119
606 Added 1.95%
31,704 $836,000
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $482,829 - $550,875
17,583 Added 130.1%
31,098 $944,000
Q4 2023

Jan 31, 2024

SELL
$26.21 - $29.22 $123,265 - $137,421
-4,703 Reduced 25.82%
13,515 $379,000
Q3 2023

Oct 23, 2023

BUY
$26.26 - $31.38 $133,663 - $159,724
5,090 Added 38.77%
18,218 $494,000
Q2 2023

Jul 13, 2023

SELL
$29.6 - $36.56 $444 - $548
-15 Reduced 0.11%
13,128 $403,000
Q1 2023

Apr 17, 2023

BUY
$32.77 - $39.4 $2,064 - $2,482
63 Added 0.48%
13,143 $473,000
Q4 2022

Jan 23, 2023

BUY
$39.17 - $44.04 $233,923 - $263,006
5,972 Added 84.02%
13,080 $0
Q3 2022

Oct 24, 2022

BUY
$39.88 - $44.65 $6,101 - $6,831
153 Added 2.2%
7,108 $286,000
Q2 2022

Aug 02, 2022

SELL
$37.53 - $44.22 $617,068 - $727,065
-16,442 Reduced 70.27%
6,955 $292,000
Q1 2022

Apr 20, 2022

BUY
$37.46 - $42.44 $8,316 - $9,421
222 Added 0.96%
23,397 $912,000
Q4 2021

Jan 31, 2022

BUY
$35.17 - $42.48 $13,399 - $16,184
381 Added 1.67%
23,175 $924,000
Q3 2021

Nov 05, 2021

SELL
$36.14 - $42.24 $49,800 - $58,206
-1,378 Reduced 5.7%
22,794 $824,000
Q2 2021

Aug 12, 2021

BUY
$39.85 - $46.63 $390,251 - $456,647
9,793 Added 68.11%
24,172 $991,000
Q1 2021

May 10, 2021

BUY
$42.34 - $52.82 $408,157 - $509,184
9,640 Added 203.42%
14,379 $627,000
Q4 2020

Feb 11, 2021

BUY
$36.12 - $50.05 $171,172 - $237,186
4,739 New
4,739 $237,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.